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Prevalence of Cardiac Abnormalities in College Athletes When Exposed to Physiological 
and Thermal Stressors 
Abstract 
Cardiovascular pre-participation screening of collegiate student athletes is inadequate. 
Physiological stress in the form of submaximal exercise and heat exposure can both alter 
cardiovascular function, possibly elucidating an abnormality via electrocardiogram (ECG). 
Purpose. 
To investigate prevalence of cardiac abnormalities in college athletes when 
exposed to physiological and thermal stress. 
Methods. 
Eleven participants (males n=5; females n=6; 20.5 ± 1.4 yrs; 167.8 ± 4.8 cm; 60.0 
± 4.5 kg; 56.1 ± 12.2 ml/kg/min) currently participating at the NCAA Division I level 
volunteered for this study. Participants completed two submaximal treadmill tests (70% 
of VO2 max) in varying environmental conditions: thermoneutral (24.8 ﾱ 1.6˚C) and 
hyperthermic (38˚C) for 30 minutes. ECGs were recorded at five minute intervals. PR 
interval duration, ST segment elevation/depression, and R and S wave voltage amplitude 
were measured; ECGs were further analyzed for abnormalities. A repeated measures 
ANOVA was used to test the effects of condition by time. 
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Results. 
No significant condition by time interactions were found for any variable 
(p>0.05). Significance across time manifested as a decreased PR interval (p<0.05), R 
wave voltage, (p<0.05), and S wave voltage (p<0.05). No main effects (p>0.05) were 
found for ECG abnormalities however; high occurrences of incomplete left bundle 
branch block (ILBBB) were found. 
Conclusion. 
Submaximal exercise in the hyperthermic condition did not significantly alter 
cardiovascular function in the parameters measured; however, the total number of ECG 
readings with abnormalities was higher in the hyperthermic condition compared to 
thermoneutral), most notable in incidences of ILBBB. 
Abstract Word Count: 245 
Keywords: electrocardiogram; heat;sudden cardiac death; cardiovascular; pre-
participation screening. 
Introduction 
It is widely accepted that coronary heart disease is the leading cause of death in the US 
today (Cardiovascular Disease Statistics, n.d.). What is perhaps less well known is that the 
leading cause of death in young athletes is a phenomenon referred to as sudden cardiac death 
(SCD) (Maron et al., 2009; cited in Drezner, Pluim, & Engebretsen, 2009). Incidence rates for 
SCD are relatively unknown due to the difficulty of comparing studies with profoundly different 
methodology and across vastly different geographic locations. A study conducted by Corrado et 
al., (2006) across a significantly large population in the Veneto region of Italy, reported 
incidence figures for SCD in young athletes (aged 12-35 years) as high as 1:28,000. These 4 
 
findings are similar to that of a recent study conducted at 11 US and Canadian cities that reported 
incidences of sudden cardiac arrest (SCA) from cardiovascular disease for children and adults 
(ages 14-24 years) at 1:27,000 (Atkins et al., 2009). With regard to the type of cardiovascular 
disease responsible for SCD in young athletes, Maron et al. (2007) suggest that hypertrophic 
cardiomyopathy (HCM) is the leading cause. In addition, Papadakis, Whyte & Sharma (2008) 
adapted the work of Maron et al. (2007), stating that 14% of SCD in young athletes can be 
attributed to arrhythmias. 
There is a substantial amount of evidence to suggest that competitive athletes may 
display abnormal electrocardiograms (ECG) as a result of their training regimes, which may alter 
both structural and/or electrical components of the myocardium (Corrado, Biffi, Basso, Pelliccia, 
& Thiene, 2009; Corrado et al., 2010; Pelliccia et al., 2000; Maron & Pelliccia, 2006; Drezner et 
al., 2009; Langdeau et al., 2001; Basavarajaiah et al., 2008; Holly, Shaffrath, & Amsterdam, 
1998; Wilson et al., 2011). Changes that have been reported include sinus bradycardia, left and 
right ventricular remodeling (including increased wall thickness and chamber size), increased left 
atrial cavity size (and volume), increased RR, PR, and QT intervals, first-degree 
(atrioventricular) AV block and Mobitz type I (Wenkebach) second-degree AV block (Corrado 
et al., 2009; Maron & Pelliccia, 2006; Langdeau et al., 2001). Up to 80% of trained athletes can 
show some of these ECG changes, often referred to as “athlete‟s heart syndrome”. These changes 
result from non life threatening physiological adaptations of the autonomic nervous system to 
athletic conditioning, including changes such as increased vagal tone and/or withdrawal of 
sympathetic activity (Holly et al., 1998). 
Rywik, O‟Conner, Gittings, Wright, Khan, & Fleg (2002) have suggested that the ECG 
response to treadmill exercise plays a significant role in the ability to diagnose and assess 5 
 
individuals with suspected coronary heart disease. The authors outlined research that have shown 
that a horizontal or down-sloping ST-segment depression ≥ 1 mm in response to exercise is a 
powerful predictor for future coronary events, including myocardial infarction and SCD, in an 
apparently healthy population (Rywik et al., 2002). In addition, exposure to heat has also been 
shown to elicit abnormal cardiac activity both in sedentary exposure (Rautaharju, Wolf, Piironen, 
Äikäs, & Karvonen, 1966) and exposure combined with some magnitude of physical exertion 
(Akhtar, Al-Nozha, Al-Harthi, & Nouh, 1993). ECG changes reported during sedentary exposure 
included shortening of the S-T segment and a flattening of the T wave in lead X (Rautaharju et 
al., 1966).  Furthermore, common changes observed during physical exertion in the heat 
included increased Q-T interval, sinus tachycardia, and diffuse ST-T changes that were highly 
suggestive of myocardial ischemia (Akhtar et al., 1993).  
These data suggest that initial incidence rates may have significantly underestimated the 
magnitude of the problem of SCD in athletes and that an exercise stress test may be conducive to 
bringing about observable cardiac abnormalities in an otherwise healthy, previously undiagnosed 
individual. Based on these data, there is a need to provide a more clear perspective of this issue, 
helping to increase awareness and improve preventative measures for athletes. The work of 
Pfister, Puffer & Maron (2000) provided data that suggest current pre-participation 
cardiovascular screening processes for US collegiate student-athletes is an area of concern. It 
was reported that only 26% of institutions analyzed used screening forms that were considered 
adequate according to the 12 recommendations of the American Heart Association consensus 
panel for pre-participation cardiovascular screening of athletes (Maron et al., 1996).  Therefore, 
the purpose of this study was to elucidate possible previously undiagnosed cardiac abnormalities 
in an otherwise healthy, NCAA Division I athlete population through exposure to a given 6 
 
workload in contrasting environmental conditions (thermoneutral and hyperthermic). We 
hypothesized that if cardiac abnormalities exist, then exercising in the heat would elicit them to a 
greater extent than in a thermoneutral environment. 
Methods 
Participants.   
Eleven participants (male n=5; female n=6) volunteered to participate in the 
study). All participants were current NCAA Division I athletes and included members of 
the golf, cross country, or track and field teams. Participants were required to report to 
the laboratory on three separate occasions for either descriptive data collection or 
treadmill testing. Participants could not participate in any testing if they met any of the 
following exclusion criteria: previously diagnosed or current cardiac abnormalities, 
family history of cardiac abnormalities, idiopathic syncope, diabetes, cancer, medications 
that affect heart rate or blood pressure, pituitary disease, amenorrhea (amenorrheic for 
three or more months not controlled by medication), history of heat related illnesses, 
thyroid disease, pregnant or planning on becoming pregnant, smokers (current or quit 
within the last six months), hypertension (blood pressure >140/90mmHg), and exercise 
induced asthma. A health history questionnaire was given to participants to screen for 
these criteria. Indiana State University‟s Institutional Review Board approved the 
experimental protocol. 
Instrumentation. 
Anthropometric Data Collection. 
Measurements were taken at seven sites, and body composition was 
determined using the Siri equation, according to standards set forth by the 7 
 
American College of Sports Medicine (Thompson, Gordon, & Pescatello, 2009). 
All skinfolds were taken by the same trained technician.  Body weight was 
measured using Transcell Technology Inc. scales (Model TI – 500 E Class III, 
Buffalo Grove, IL) and height was measured using a standard standiometer.   
Electrocardiogram. 
ECG readings were taken prior to any treadmill testing (Burdick Atria 
6100, Deerfield, WI). Readings were taken while participants were seated, 
standing, and supine prior to taking part in any of the three tests (maximal or 
submaximal).  Standard 12-lead electrode placement was used (see Figure 1).  
 
Figure 1. 12 lead ECG electrode placement. 
       
Respiratory Data Collection. 
A Medgraphics metabolic cart (Model Ultima CPX, St. Paul, MN) was 
used to collect breath by breath data. Heart rate was collected during the max test 
using a Polar heart rate monitor (Model RS200SD, Lake Success, NY) and was 
monitored during the submaximal tests through the Atria 6100. 8 
 
Maximal Aerobic Test. 
The maximal aerobic test was performed on a treadmill (Model 
Trackmaster TMX425CP, St. Paul, MN) and followed a previously published 
protocol (Paavolainen, Häkkinen, Hämäläinen, Nummela, & Rusko, 1999). 
Participants were deemed to have reached VO2 max according to commonly used 
criteria (plateau in VO2 consumption despite an increase in workload, heart rate ≥ 
age predicted maximum, RER ≥ 1.15, RPE of 19 or 20). Following completion of 
the test, the gradient was immediately returned back to 0%, treadmill speed 
reduced, and participants were required to remain jogging/walking on the 
treadmill until their heart rate returned to within 20-30 bpm of recorded resting 
heart rate. Fluids were available ad-libitum during the recovery phase. 
Submaximal Treadmill Tests. 
  After a minimum of 48 hours of rest after the maximal exercise test, 
participants performed two submaximal treadmill tests at 70% of their pre-
determined VO2 max in different environmental conditions on two different days 
separated by at least 48 hours.  The test days included submaximal tests in a 
thermoneutral and hyperthermic environment for up to 30 minutes. The order of 
tests was randomized. Participants remained connected to the ECG machine while 
exercising at 70% of their pre-determined VO2 max. Momentary pauses of 30-40 
seconds took place at five-minute intervals in order to gain ECG readings with as 
little interference as possible with the participant straddling the treadmill. Once 
the reading was printed, participants resumed running. Fluids were available ad-
libitum throughout the test.  9 
 
Statistical Analysis. 
The baseline characteristics of the groups were analyzed using one-way analysis 
of variance (ANOVA). A 2 x 4 repeated measures ANOVA was used to test the effects of 
condition (thermoneutral, hyperthermic) by time (baseline, 5 minutes, 10 minutes, 15 
minutes) on the changes in R and S wave voltage amplitude, PR interval duration, and ST 
elevation/depression. The analysis of ECG abnormalities was performed by coding the 
ECG based on adapted criteria from Pelliccia et al. (2000). If an interaction was deemed 
significant, a Tukey‟s HSD test was used for post-hoc comparisons.  Significance was set 
a priori at p<0.05.  Values are presented as mean ± SD.  All statistical analyses were 
performed using SPSS Version 18 (SPSS, Inc., Chicago, IL, USA).   
Results 
Participant and Environmental Characteristics. 
  Participants were all NCAA Division I athletes involved in golf (n=2), cross 
country (n=8), and track and field (n=1). Participant descriptive data are presented in 
Table 1. One participant (cross country) of the original study population of 12 only 
completed two of the three tests (maximal and thermoneutral) and was therefore dropped 
from the analysis. The average running time in the thermoneutral and hyperthermic 
submaximal tests was 23.6 ± 8.4 minutes and 20.9 ± 7.7 minutes (p>0.05) respectively. 
Average laboratory temperature during the maximal and thermoneutral submaximal tests 
was 24.8 ﾱ 1.6˚C (23.3 – 27.8˚C). Environmental chamber temperature was set at 38˚C 
for the hyperthermic submaximal tests. 
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Thermoneutral versus Hyperthermic across Exercise Time. 
  There was no significant condition by time effect found for any of the parameters 
(PR interval, F1,6=0.870, p>0.05; R wave voltage, F1,6=0.861, p>0.05; S wave voltage, 
F1,6=0.607, p>0.05; ST segment position, F1,6=1.157, p>0.05) (Figures 2, 3, 4, and 5 
respectively). In addition, no significant difference was found with regard to coding the 
ECGs for abnormalities based on criteria outlined by Pelliccia et al. (2000) (F1,6=0.571, 
p>0.05) for the interaction of condition by time.   
Thermoneutral versus Hyperthermic. 
No significant main effects of environment were found between PR interval 
(F1,6=0.557, p>0.05), or S wave voltage amplitude (F1,6=0.049, p>0.05) (Figures 2 and 4 
respectively). In addition, changes in R wave voltage and ST segment position were not 
statistically significant but there was an increased R wave amplitude in the hyperthermic 
condition and increased ST segment alterations from baseline in the thermoneutral tests 
(F1,6=4.250, p=0.073; and F1,6=3.883, p=0.084 respectively) (Figures 3 and 5 
respectively). No significant difference in occurrence of ECG abnormalities was 
observed (F1,6=0.023, p>0.05) between environmental conditions according to Pelliccia et 
al. (2000) criteria.  However, there were significantly (p<0.05) more ECG readings 
presenting waveform patterns that demonstrated incomplete left bundle branch block 
(ILBBB) in the hyperthermic (n=8) compared to the thermonuetral test (n=4). 
Exercise Time. 
Significant main effects were observed in several of the parameters across time 
such that PR interval decreased from rest at five, 10 and 15 minutes (F1,6=31.343, 
p<0.05) (Figure 2), R wave voltage amplitude decreased at five, 10 and 15 minutes from 11 
 
rest (F1,6=10.613, p<0.05) (Figure 3) and; S wave voltage amplitude increased at five, 10 
and 15 minutes from rest (F1,6=9.706, p<0.05) (Figure 4). No significant difference in 
occurrence of ECG abnormalities was observed (F1,6=0.227, p>0.05) across time. 
Discussion 
The results of the present study suggest that cardiac abnormalities not attributed to 
common athletic training adaptations, may be elucidated more frequently through submaximal 
running in a hyperthermic environment compared to a thermoneutral environment. The results 
demonstrate that 25.8% of ECG readings in the hyperthermic environment displayed waveforms 
consistent with ILBBB compared to 12.9% in thermoneutral (Table 2). These incidences contrast 
greatly to results presented in the work of Akhtar et al. (1993), in which none of the patients 
suffering from heat stroke, showed ECG waveform patterns consistent with left bundle branch 
block (LBBB).  
While not statistically significant, perhaps the most physiologically significant results 
came from the abnormality analyses (Pelliccia et al. (2000). While normal cardiovascular 
responses to exercise such as a decrease in PR interval duration classified some ECGs as „mildly 
abnormal‟ , several resting and exercise ECGs showed conditions that have been widely 
documented as innocent adaptations or “athlete‟s heart syndrome”. These changes included sinus 
bradycardia, left ventricular hypertrophy (LVH), and incomplete right bundle branch block 
(IRBBB). Electrical and/or structural alterations to the heart of athletes, including those 
mentioned, have been reported in a number of studies (Corrado et al., 2009; Corrado et al., 2010; 
Pelliccia et al., 2000; Maron & Pelliccia, 2006; Drezner et al., 2009; Langdeau et al., 2001; 
Basavarajaiah et al., 2008; Holly, Shaffrath, & Amsterdam, 1998), most notably in athletes 
involved in endurance sports such as long-distance running, cycling, and rowing/canoeing 12 
 
(Langdeau et al., 2001; Pelliccia et al., 2000). Results from the present study showed that 10 of 
the 11 participants had one or more of these common adaptations, either at rest, during exercise, 
or both at rest and during exercise (Table 2). In total, 82% of participants in the present study 
showed LVH at rest and 91% during exercise. IRBBB was seen in 45% of participants at rest, 
and 45% during exercise, regardless of condition (Table 2). With regard to displaying more than 
one abnormality, a total of four participants produced readings either at rest or during exercise 
that showed a combination of LVH and either IRBBB or ILBBB. In addition, an additional four 
participants displaying readings that demonstrated a combination of all three abnormalities 
during rest and/or exercise. While this incidence rate may appear to be abnormally high, it is not 
uncommon. Similar incidence rates have been reported previously, with up to 80% of athletes 
across various studies presenting some type of cardiac abnormality (Holly et al., 1998). That 
statistic, combined with the study population being composed of primarily long-distance runners, 
makes the incidence rate of 91% in the present study understandable. What is perhaps most 
concerning, is that several participants produced ECG readings that met common criteria for 
ILBBB, an abnormality not usually associated with normal adaptations to athletes‟ hearts 
(Corrado et al., 2010; Wilson et al., 2011). Due to greater prevalence of ILBBB in the 
hyperthermic environment in the present study, it may be of benefit that athletes be evaluated in 
varying environmental conditions as part of cardiovascular pre-screening, as uncommon 
abnormalities may show in one condition more frequently than the other. 
With regard to the prevalence of these abnormalities, the present study demonstrated 
similar incidence rates of LVH and IRBBB („normal‟ adaptations) as reported in the work of 
Wilson et al. (2011).  Wilson et al. (2011) observed these and other common training adaptations 
in the ECGs of 96.7% of the Caucasian athletes examined. More specifically, IRBBB was 13 
 
observed in 60% of Caucasian athletes examined; a considerably higher occurrence rate than 
LVH in the same population (Wilson et al., 2011). Similarly, Corrado et al. (2010) outlined data 
that suggests high IRBBB incidence rates in athletes, reporting occurrences of 35 to 50%, 
compared to just 10% in young, healthy individuals. Data from Langdeau et al. (2001) suggest 
that the right ventricular conduction delay is caused by an enlarged right ventricle cavity size 
and/or increased cardiac muscle mass and the resultant increased conduction time. Despite the 
high prevalence of IRBBB reported in athletes (Wilson et al., 2011; Pelliccia et al., 2000; 
Langdeau et al., 2001), Corrado et al. (2010) suggested that further examination is not required 
in the presence of negative family/personal history and physical examination. In addition, Fagard 
et al. (1983) suggested that the right bundle branch block (RBBB) morphology is reversible with 
deconditioning.  Based on data from the present study, prevalence of IRBBB among participants 
at rest and during exercise was similar to what has been observed in previous studies (Wilson et 
al., 2011; Pelliccia et al., 2000; Langdeau et al., 2001) and can be attributed to a common and 
non-threatening adaptation of athlete‟s hearts to exercise training. 
In the present study, changes observed on the exercise ECGs related to exercise time, 
while not necessarily statistically significant but may still be clinically relevant, included 
shortening of PR interval duration, alterations in R wave voltage amplitude, and alterations in S 
wave amplitude, were expected, and have been reported in previous studies (Nakamoto, 
Matsukawa, Murata, & Komine, 2005; Wolthuis, Froelicher, Hopkirk, Fischer, & Keiser, 1979; 
Deckers, Vinke, Vos, & Simoons, 1990; Baron, Ilsley, Sheiban, Poole-Wilson, & Rickards, 
1980). While a decreased PR interval was expected during exercise, two participants displayed 
considerably short PR intervals (≤120 ms) at rest placing those ECGs in the “mildly abnormal” 
category (Pelliccia et al., 2000). None of the participants presented a prolonged PR interval 14 
 
(≤200 ms) at rest or during exercise; an abnormality reported in previous studies by Wilson et al. 
(2011) and Pelliccia et al. (2007). R wave amplitude alterations followed similar patterns as 
observed in the work of Wolthius et al. (1979) and Baron et al. (1980), whereby amplitude 
initially decreased from resting levels once exercise commenced, but as exercise continued, 
amplitude once again increased after heart rate rose above 140 bpm (Figure 3). In the present 
study, S wave progression followed similar changes as observed by Wolthius et al. (1979), 
whereby as exercise duration increased, S wave voltage amplitude became more negative. Taken 
together these data demonstrate voltage amplitude progression similar to what has been observed 
in previous studies (Wolthius et al., 1979; Baron et al., 1980) and should be expected as normal 
ECG waveform patterns during athletic activity. 
In contrast to the widely reported prevalence of common ECG changes in athletes, only 
5.8% of the Caucasian athletes in the Wilson et al. (2011) study showed uncommon ECG 
changes, such as LBBB, ST segment depression, and right ventricular hypertrophy.  This is 
compared to 55% (n=6) of the present study which presented ECGs displaying waveform 
deformities indicative of ILBBB (either at rest and/or during exercise). More specifically, only 
one athlete out of the total Caucasian athlete population displayed ILBBB (Wilson et al., 2011).  
In the present study, the high prevalence of ILBBB could be explained by the same disturbances 
in conduction seen in athletes related to physiological hypertrophy of the heart (Chapman, 1977). 
While cases of ILBBB are nearly always associated with organic heart disease, most often 
ischemic or hypertensive in origin, Chapman (1977) has outlined previous research that have 
reported findings of ILBBB in patients with apparently normal hearts. In addition, Chapman 
(1977) presented a case study in which a 30 year old male (in very good physical condition) 
presented ECG readings with intermittent ILBBB, where the block was present at rest (heart rate 15 
 
of 78 to 85 bpm), but also appeared during exercise at a heart rate greater than180 bpm (although 
it was not present at a rate of 175 bpm). The findings of Chapman (1977) may help to explain the 
high prevalence of ILBBB found in the present study. However, it should not completely exclude 
the possibility of a previous myocarditis, and therefore further evaluation upon discovery of 
ILBBB in athletes should be utilized in order to better understand the underlying cause.  
Also of interest in the present study was the high rate of abnormalities found in female 
athletes in the study.  This is in contrast to previous studies reporting that female athletes 
generally present ECG abnormalities considerably less than male athletes (Pellicccia et al., 2000; 
Langdeau et al., 2001). This could be in large part due to a small study population, and a more 
significant study population may yield female prevalence of cardiac abnormalities at a rate more 
similar to what has previously been demonstrated. In addition, inclusion of athletes involved in a 
wider range of sports that utilize power/explosiveness more than cardiovascular endurance may 
alter ECG abnormality prevalence.  
As previously discussed, current cardiovascular pre-participation screening for college 
athletes in the US have been reported to be largely inadequate at many institutions across the 
country (Pfister et al., 2000), however, this issue is not limited to north America. Many health 
professionals across Europe support the need for a 12-lead ECG to screen for potential cardiac 
abnormalities in young athletes (Corrado et al., 2005; Corrado et al., 2009). While the present 
study used a specific population, it is hard to ignore the striking prevalence in ILBBB given the 
comparatively low incidence rates in previous studies (Corrado et al., 2010; Wilson et al., 2011). 
While many athletes may show ECG abnormalities that are normal adaptations to training, 
abnormalities that are less common (such as ILBBB) should be of more concern.  Furthermore, if 
a simple test of cardiac form and function combined with heat stress can elucidate these 16 
 
abnormalities, incidences of SCD in college student-athletes could potentially be reduced, or 
perhaps prevented altogether. 
It is important to note that the participants in the present study were not necessarily 
acclimatized to the hyperthermic environment. Heat acclimatization is the collective physiologic 
adaptive changes to exercising in the heat can be made by the body that allows for improvement 
in tolerance to heat exposure such as improved cutaneous blood flow, lowered threshold for the 
start of perspiration, lowered salt concentration of perspiration, and less reliance on carbohydrate 
catabolism during exercise. Other changes observed as a result of heat acclimatization include a 
decrease in heart rate and core body temperature (indicative of lessened physiologic strain) as 
well as an increase in blood plasma (Casa, 1999). 
Conclusion 
This study has suggested that submaximal running in contrasting environmental 
conditions does not elicit a significant difference in ECG parameters of PR interval duration, R 
wave voltage amplitude, S wave voltage amplitude, or ST segment elevation/depression. 
While a significant interaction between conditions was not observed, this study reported a 
high prevalence of ILBBB at various stages of exercise in both environments. This high 
incidence rate lends support to the body of discussion that already exists around implementing 
more thorough pre-participation screening protocols for young athletes as a means to reduce 
SCD in this population. It should be noted that in light of the increased prevalence of ILBBB in 
hyperthermic conditions, athletes that train in areas with warmer climates may benefit from 
submaximal ECG screening in a hyperthermic environment.   
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Table 1. Participant Group Demographics (mean ± SD). 
Age (years)  20.5 ± 1.4 
Height (cm)  167.8 ± 4.8 
Weight (kg)  60.0 ± 4.5 
VO2 Max (ml/kg/min)  56.1 ± 12.2 
Body Fat (%)  14.4 ± 7.9 
Body Density  1.066 ± 0.018 
 
Table 2. Percentage of ECG Readings Taken at Time Intervals Presenting LVH, IRBBB, and/or 
ILBBB Between Test Conditions (actual number of ECGs in parentheses). 
Condition  Time (mins)  LVH  IRBBB  ILBBB 
Thermoneutral  5  91% (10/11)  18% (2/11)  18% (2/11) 
10  91% (10/11)  18% (2/11)  9% (1/11) 
15  78% (7/9)  33% (3/9)  11% (1/9) 
Hyperthermic  5  64% (7/11)  18% (2/11)  27% (3/11) 
10  50% (5/10)  30% (3/10)  20% (2/10) 
15  80% (8/10)  10% (1/10)  30% (3/10) 
 
LVH=Left ventricular hypertrophy; IRBBB=Incomplete right bundle branch block; 
ILBBB=incomplete left bundle branch block. 
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Figure 2. Mean PR interval duration alterations by condition and exercise time. 
Data are mean ± SEM 
*p<0.05, significant difference from rest in both conditions. 
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Figure 3. Mean R wave amplitude alterations by condition and exercise time. 
Data are mean ± SEM 
*p<0.05, significant difference from rest in both conditions. 
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Figure 4. Mean S wave amplitude alterations by condition and exercise time. 
Data are mean ± SEM 
*p<0.05, significant difference from rest in both conditions. 
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Figure 5. Mean ST segment alterations from baseline by condition and exercise time. 
Data are mean ± SEM 
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Chapter 1: Development of the Study 
Introduction 
It is widely accepted, that coronary heart disease is the leading cause of death in the US 
today (Cardiovascular Disease Statistics, n.d.).  Data suggest that in 2005, 652,091 deaths were 
attributed to some form of heart disease, accounting for 27.1% of all US deaths for that year 
(Kung, Hoyert, and Murphy, 2008; cited in “Heart Disease Facts and Statistics”, 2009). What is 
perhaps less well known is that the leading cause of death in young athletes is a phenomenon 
referred to as sudden cardiac death (SCD) (Maron et al., 2009; cited in Drezner, Pluim, & 
Engebretsen, 2009). Incidence rates for SCD are relatively unknown due to the difficulty of 
comparing studies with profoundly different methodology and across vastly different geographic 
locations.  This leads many estimates to be based upon public media reports and other electronic 
databases (Drezner, et al., 2009). Some studies have estimated that between 1:160,000 to 
1:300,000 competitive athlete deaths in the US can be attributed to cardiovascular diseases 
(Maron et al., 2009; Van Camp et al., 2009; cited in Drezner, et al., 2009).  However, a recent 
study conducted by Corrado et al., (2006) across a significantly large population in the Veneto 
region of Italy, reported incidence figures for SCD in young athletes (aged 12-35 years) as high 
as 1:28,000. These findings are similar to that of a recent study conducted at 11 US and 
Canadian cities that reported incidences of sudden cardiac arrest (SCA) from cardiovascular 
disease for children and adults (ages 14-24 years) at 1:27,000 (Atkins et al., 2009). With regard 
to the type of cardiovascular disease responsible for SCD in young athletes, Maron et al. (2007) 29 
 
suggest that hypertrophic cardiomyopathy (HCM) is the leading cause, with analysis of 1435 
cases of SCD in young competitive athletes revealing 36% of deaths could be attributable to 
HCM. Papadakis, Whyte & Sharma (2008) further adapted the work of Maron et al. (2007), 
stating that 14% of SCD in young athletes can be attributed to arrhythmias.  
Rywik et al. (2002) suggested that the electrocardiographic response to treadmill exercise plays a 
significant role in the ability to diagnose and assess individuals with suspected coronary heart 
disease. The authors outlined research that has shown that a horizontal or down-sloping ST-
segment depression ≥ 1 mm in response to exercise is a powerful predictor for future coronary 
events, including myocardial infarction and SCD, in an apparently healthy population. 
The findings outlined suggest that initial incidence rates may have significantly 
underestimated the magnitude of the problem of SCD in athletes and that an exercise stress test 
may be conducive to bringing about observable cardiac abnormalities in an otherwise healthy, 
previously undiagnosed population. Therefore, there is a need to provide a more clear 
perspective of this issue, helping to increase awareness and improve preventative measures for 
athletes. 
Statement of the Problem 
Current standards of cardiovascular pre-participation screening for American collegiate 
student-athletes are inadequate (Pfister, Puffer, & Maron, 2000).  Many health care professionals 
throughout Europe are proposing that a standard 12-lead electrocardiograph (ECG) in addition to 
current forms of screening would aid in the ability to accurately detect potential cardiac disorders 
in young athletes (Corrado et al., 2005). The present study may help further expand on the 
current literature on incidence rates of cardiac abnormalities in an athletic population and aid in 30 
 
the discussion to implement a more comprehensive cardiovascular pre-participation screening 
process for collegiate athletes in the US.  
Purpose of the Study 
The purpose of this study was to examine the incidence rate of cardiac abnormalities in a 
collegiate athletic population through exposure to physiological and thermal stressors.  
Limitations 
1.  Availability of athletes for testing. 
2.  Each individual brought a certain amount of variability with them that presented a threat 
to the validity of the study. 
Delimitations 
1.  The study was limited to students currently enrolled at Indiana State University; therefore 
results can only be applied to collegiate athletes that meet the inclusion criteria for the 
study.  
2.  The study only included athletes from the golf, cross country, and track and field teams 
of Indiana State University, therefore results cannot be applied to other NCAA Division I 
athletes participating in sports other than those mentioned. 
3.  Heat stress test was performed in a controlled environmental chamber. 
4.  Physiological stress came in the form of controlled treadmill running. 
Hypothesis 
It has been suggested that athletes may have some form of underlying, undiagnosed 
cardiac abnormality that may result in increased incidence rates of SCD (Corrado et al., 2006). 
If athletes have these undiagnosed cardiac abnormalities, then simple tests of cardiac form and 
function in response to acute physiological and thermal temperatures may elucidate them. 31 
 
Therefore, it was hypothesized that if collegiate athletes are exposed to appropriate physiological 
and thermal stressors, any undiagnosed cardiac abnormalities will manifest on an ECG 
(APPENDIX C). To test this hypothesis, collegiate student-athletes underwent an ECG test 
before a maximal stress test, and during submaximal stress tests performed in a thermoneutral 
and a hyperthermic environment. 
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Chapter 2: Review of Literature 
Prevalence and Common Types of Cardiac Abnormalities in Athletes 
Pelliccia et al. (2007) examined data of a significant subject population that was 
predominantly young amateur male athletes (80%) involved in sports such as soccer, volleyball, 
basketball, and athletics. Based off commonly used clinical criteria for evaluating ECG patterns, 
11.8% of the population showed abnormal 12-lead ECG patterns, with the most common 
abnormalities present being a prolonged PR interval, incomplete right bundle branch block 
(IRBBB) and early repolarization pattern (Pelliccia et al., 2007). Distinct ECG abnormalities 
also found included deeply inverted T-waves in .2 precordial and/or standard leads and increased 
R/S wave voltages suggestive of left ventricular hypertrophy (LVH) (Pelliccia et al., 2007). 
In terms of the most prevalent cardiac abnormalities related to SCD, the work of Corrado, 
Basso, Schiavon, & Thiene (1998) in examining the effectiveness of the pre-participation 
screening program adopted in Italy, has suggested that arrhythmogenic right ventricular 
cardiomyopathy (ARVC) is the leading cause of death among young athletes (age ≤35 years). 
Since 1971, Italian law has required that every athlete undergo an annual clinical evaluation in 
order to be approved to take part in competitive sports. A competitive athlete is defined as “a 
participant in an organized sports program requiring regular training and competition” (Maron et 
al., 1996).  From 1979 to1996, a consecutive series of 33,735 young athletes (28,539 male and 
5196 female athletes with a mean age of 19 ± 5 years) in the Veneto region of Italy underwent 
pre-participation cardiovascular screening. The cardiac disease screening process was part of a 33 
 
more comprehensive medical examination that consisted of general clinical history taking 
physical examinations, orthopedic examinations, spirometry, and urinalysis (Corrado et al, 
1998). The initial cardiovascular testing protocol began with taking family and personal history, 
physical examination (including testing blood pressure), basal 12-lead ECG, and limited exercise 
testing. Additional tests including echocardiography and 24-hour ambulatory Holtner monitoring 
were requested for subjects who had positive findings, such as syncope or near-syncope, chest 
pain or discomfort, and irregular heartbeat or palpitations on exertion (Corrado et al., 1998). 
Aside from ARVC (22.4%), the most common causes of sudden death in athletes were coronary 
atherosclerosis (18.4%) and anomalous origin of a coronary artery (12.2%), with HCM 
accounting for only one sudden death (2.0%) among athletes (although it was more common in 
non-athletes at 7.3%) (Corrado et al., 1998). The relatively low incidence rate of HCM reported 
by Corrado et al. (1998) differs considerably from similar research coming out of the US, in 
which causes of cardiac arrest in younger competitive athletes have been attributed to HCM, 
accounting for about one third of fatal cases (Maron et al., 2007). Similarly, Maron et al., (2003) 
examining deaths in young competitive athletes, reported that of the 286 documented 
cardiovascular deaths, most were due to HCM (36%) or anomalous coronary artery of wrong 
sinus origin (13%), such as Wolfe-Parkinson-White syndrome. 
Maron, Roberts, McAllister, Rosing, & Epstein (1980) examined the cases of 29 athletes; 
of which, 22 had died during or shortly following severe exertion on the athletic field. Their 
findings showed that in 28 of the 29 athletes studied, structural heart disease was identified and 
was likely the cause of sudden death in 22 of those cases, with HCM accounting for almost half 
of the deaths (14 out of 29) in the series (Maron et al., 1980). Perhaps one of the more 
concerning statistics that arose from this study was that cardiac disease was unrecognized during 34 
 
life in most of the athletes, with only two receiving a correct diagnosis ante mortem (Maron et 
al., 1980).  
The work of Hebbar & Hueston (2002) supported those findings, suggesting that 
malignant ventricular tachycardia is perhaps the arrhythmia that is of most concern to athletes 
and is usually associated with idiopathic HCM. 
Differences in Athlete ECG Readings Related to Ethnic Background 
As previously mentioned, HCM is the most common structural cardiovascular finding 
that can be attributed to sudden death in US athletes, with the condition being considerably more 
prevalent in African-American athletes than Caucasian athletes (Magalski et al., 2008; Maron, 
Doerer, Has, Tierney, & Mueller 2009; Basavarajaiah et al., 2008; Maron et al., 2003). Research 
by Maron et al. (2003) on a number of sudden deaths in young athletes showed that of the deaths 
attributable to HCM, 55 percent were African-American compared to 41 percent Caucasian. A 
study conducted by Magalski et al. (2008) on elite American football players reported abnormal 
ECG patterns in 25% of the athletes tested, with abnormal readings significantly more common 
among African-American players (30%) compared with Caucasian players (13%) or other races 
(15%). In addition, distinctly abnormal ECG patterns that were suggestive of cardiac disease 
were also more common in African-American players (6%) compared with Caucasian (2%) 
(Magalski et al., 2008). It was suggested that this significant difference in prevalence among 
races can at least be partly attributed to physiological cardiovascular differences that are 
common between non-Caucasian and Caucasian athletes, namely increased left ventricular (LV) 
wall thickness and cavity size in non-Caucasian athletes (Basavarajaiah et al., 2008). Non-
Caucasian athletes develop a greater magnitude of left ventricular hypertrophy (LVH) compared 
with Caucasian athletes, which has the potential to increase the likelihood of generating false-35 
 
positive diagnoses of HCM in non-Caucasian athletes (Basavarajaiah et al., 2008). Maron et al. 
(2009) examined sudden deaths in young competitive athletes in the US from 1980-2006, 
analyzing a total of 1866 deaths. While the absolute number of cardiovascular deaths reported in 
Caucasian athletes (581; 55%) exceeded that in African-American athletes (377; 36%) and other 
minority races, the number of deaths due to cardiovascular disease was higher in non-Caucasian 
than Caucasian athletes (64% and 51%, respectively) (Maron et al., 2009). In addition, non-
Caucasian athletes (predominantly African-Amercian) had a higher number of reported deaths 
attributable to HCM and congenital coronary anomalies than Caucasian athletes, with 136/676 
(20%) compared with 112/1135 (10%) for HCM, and 66/676 (10%) versus 52/1135 (5%) for 
coronary abnormalities (Maron et al., 2009). Conversely, Caucasian athletes had a higher 
fraction of reported deaths attributable to ion channelopathies (22/1135; 2%) compared to 2/676 
(0.3%) among non-Caucasian athletes (Maron et al., 2009).  
Gender Differences in Abnormal ECG Readings and Sudden Death Frequency Among 
Athletes 
Pelliccia, et al. (2000) reported findings that displayed a significant discrepancy in the 
frequency of distinctly abnormal (17% versus 8%), or mildly abnormal (28% versus 14%), ECG 
readings in trained male and female athletes.  It was demonstrated that male athletes showed 
greater maximum R or S wave voltages and more frequently abnormal Q waves compared to 
female athletes. In addition, there was a marked difference in the number of female athletes that 
displayed normal ECGs (78%) compared with male athletes (55%) (Pelliccia et al., 2000). 
Langdeau, Blier, Turcotte, O‟Hara, & Boulet (2001) examined heart abnormalities in athletes, 
and reported that male long-distance runners had a considerably higher incidence rate of cardiac 
abnormalities.  There were none of the female long-distance runners examined that showed left 36 
 
ventricular hypertrophy (LVH) or incomplete right bundle branch block (IRBBB), compared to 
six of 10 males that presented with LVH, four of seven IRBBB, and two with both abnormalities.   
With regard to gender differences in incidence rates of SCD in athletes, the sheer size of 
the sample population used by Carrado et al. (1998) provides the most comprehensive data set. 
Of the 269 sudden deaths that occurred from 1979 to 1996 in people 35 years of age or less in the 
Veneto region of Italy, 49 were among competitive athletes (44 male and 5 female) out of a total 
sample of 28,539 male, and 5,196 female athletes (0.15% and 0.10% respectively). In a separate 
article, Corrado et al. (2005) highlights the significant male athlete predominance in sudden 
death incidences, and suggests that this predominance can be related to the higher participation 
rate of male compared with female athletes in competitive sports.  In addition, males generally 
uitilzed a more intensive training load and higher levels of athletic achievement. More recently, 
it has been proposed that male gender in itself is a risk factor for sports-related sudden death.  
This is most likely due to the greater prevalence and/or phenotypic expression in young males of 
cardiac diseases at risk of arrhythmic cardiac arrest (Corrado et al., 2005). 
Common ECG Changes Observed in Athletes as a Result of Training 
There is a substantial amount of evidence to suggest that competitive athletes may 
display abnormal ECGs as a result of their training regimes, which may alter both structural 
and/or electrical components of the myocardium (Corrado, Biffi, Basso, Pelliccia, & Thiene, 
2009; Corrado et al., 2010; Pelliccia et al., 2000; Maron & Pelliccia, 2006; Drezner et al., 2009; 
Langdeau et al., 2001; Basavarajaiah et al., 2008; Holly, Shaffrath, & Amsterdam, 1998; Wilson 
et al., 2011). Changes that have been reported include sinus bradycardia, left and right 
ventricular remodeling (including increased wall thickness and chamber size), increased left 
atrial cavity size (and volume), increased RR, PR, and QT intervals, first-degree 37 
 
(atrioventricular) AV block and Mobitz type I (Wenkebach) second-degree AV block (Corrado 
et al., 2009; Maron & Pelliccia, 2006; Langdeau et al., 2001). Up to 80% of trained athletes can 
show some of these ECG changes that result from physiological adaptation of the autonomic 
nervous system to athletic conditioning, including changes such as increased vagal tone and/or 
withdrawal of sympathetic activity (Holly et al., 1998). 
   These structural and electrical changes have been observed across a wide variety of 
sports, but are more commonplace in endurance events such as long-distance running, cycling, 
rowing/canoing, and cross-country skiing (Langdeau et al., 2001; Pelliccia et al., 2000). This 
phenomenon is commonly referred to as “athlete heart syndrome” and is a crucial factor to 
consider when analyzing ECG tracings of trained athletes.  These innocent adaptations are a 
result of long-term, intense physical conditioning, which could potentially be misconstrued as 
abnormal and result in a false-positive diagnosis of a cardiac disorder (Pelliccia et al., 2000). 
Sport Participation and Potential Issues for Athletes Diagnosed With or Suspected of 
Having a Cardiac Abnormality 
As was the case of Corrado et al. (1998, 2006), part of the screening process involved 
investigating the family history of the individual concerned, looking for possible warning signs, 
or „red flags‟, that may increase the likelihood that the individual is possibly at risk from a 
cardiac disorder. Hebbar & Hueston (2002) suggest that symptoms of syncope or near-syncope 
with exercise, or a family history of SCD in a close relative are significant warning signs of the 
presence of idiopathic HCM. In addition, if an athlete has an aortic murmur that increases while 
performing a Valsalva maneuver, a sympathetic stimulator, they should be evaluated for HCM 
before being allowed to participate in sports (Hebbar & Hueston, 2002). Furthermore, if HCM is 
identified, treatment with a beta blocker or a calcium channel blocker may reduce cardiac 38 
 
contractility and heart rate (HR) during exertion.  Or alternatively, the insertion of an implantable 
cardioverter-defibrillator may be required to regulate HR during exercise (Hebbar & Hueston, 
2002). In terms of participation in sports, Hebbar & Hueston (2002) and Pelliccia et al. (2005) 
agreed that a restrictive attitude should be employed, and participation in strenuous sports should 
be avoided in athletes with HCM. Mitchell et al. (1994) present low-intensity sports such as 
bowling, golf, and billiards as possible alternatives (cited in Hebbar & Hueston, 2002). An 
interesting point is also raised by Hebbar & Hueston (2002) in which they outline reports of 
high-performance athletes frequently complaining of diminished performance or fatigue while 
taking medications.  This in turn may lead them to be non-compliant with treatment, thus putting 
them at further risk of SCD.  
Current Cardiovascular Pre-participation Screening Protocols for Athletes and the 
Argument For and Against Changes 
As previously mentioned, the extensive work of Corrado et al. (1998, 2006) investigating 
the effectiveness of screening athletes prior to taking part in competitive sports has provided 
significant results.  This is highlighted by a substantial decrease in incidence rates of SCD in 
young athletes in the Veneto region of Italy since the implementation of the screening program 
almost 30 years ago. During the period of 1979-1980, the incidence rate was 3.6 deaths per 
100,000 persons (8 sudden deaths) and throughout 1981-1982 it had increased to 4.0 deaths per 
100,000 persons (9 sudden deaths). Following this, however, the annual death rate decreased 
markedly over time until the 2001-2004 period, at which point there were only 0.43 deaths per 
100,000 persons (one sudden death each year period) (Corrado et al., 2006). The greatest decline 
in causes of SCD was seen in arrhythmogenic right ventricular cardiomyopathy, from 0.9 deaths 39 
 
per 100,000 persons during the pre-screening period (1979-1981) to 0.15 deaths per 100,000 
persons in the late screening period (1993-2004); a decrease of 84 percent (Corrado et al., 2006). 
The success of the pre-participation screening program in Italy has prompted the medical 
field to propose a common European protocol for sport pre-participation screening.   
Cardiovascular specialists and other physicians from various European countries that have 
extensive clinical experience in dealing with young competitive athletes suggest a process that is 
essentially based on a 12-lead ECG (in addition to the more common practice of taking personal 
and family history and physical examination) (Corrado et al., 2005). In the US, the current 
screening process excludes the use of an ECG as it is not seen as a cost-effective method due to 
the relatively low incidence rate of SCD in athletes and the possibility of inaccurate diagnoses 
due to inexperience of the tester (Maron, Gohman, & Aeppli, 1998; Williams & Chen, 2003). 
However, it is possible that it may enhance the sensitivity of the screening process and 
potentially allow for more effective detection of cardiovascular diseases (Corrado et al., 2009).  
The current process utilized in the US has been shown to be somewhat ineffective, with one 
retrospective analysis on 134 high school and collegiate athletes that died suddenly, revealing 
that only 3% of the examined athletes were suspected of having a cardiac abnormality, with only 
1% eventually receiving an accurate diagnosis (Maron, et al., 1996). In addition, Pfister, Puffer 
& Maron (2000) examined the current pre-participation cardiovascular screening process for US 
collegiate student-athletes. Of the screening forms analyzed from 625 institutions, only 163 
schools (26%) had forms that contained at least 9 of the recommended 12 American Heart 
Association (AHA) screening guidelines. These forms were considered adequate, whereas forms 
that contained four or fewer of these questions (24%) were considered to be inadequate (Pfister, 
et al., 2000). Other findings from the study revealed that NCAA Division I schools were more 40 
 
likely to have adequate screening forms than Division II and III schools, and often those 
responsible for performing examinations of the athletes were considerably inexperienced in the 
area of cardiovascular abnormalities.  This prompted the authors to suggest that changes need to 
be made to improve effectiveness of the screening process (Pfister, et al., 2000). 
Common Physiological Responses during Exposure to Heat 
Responses to Heat at Rest. 
 Physiological responses to changes in temperature are regulated by the 
hypothalamus, which acts to maintain a core body temperature of 37˚C ﾱ 1˚C via two 
mechanisms.  One mechanism is thermal receptors in the skin, and the other through 
changes in the temperature of blood that perfuses the hypothalamus. Thermal 
homeostasis is maintained by achieving a balance between heat gain and heat loss from 
the body. The two recognized sources of heat load are environmental (heat either being 
gained or lost) and metabolic (generated by muscular activity) (McArdle, Katch & Katch, 
2007). 
The mechanisms of convection, conduction, radiation, and evaporation are 
responsible for regulating heat exchange between the body and the external environment, 
with the effectiveness of these mechanisms decreasing as ambient temperature increases 
(McArdle, Katch & Katch, 2007).  
Convection. 
The term convection refers to the repetitive process of cool air taking the 
place of warm air as it rises from the surface of the skin (due to warm air being 
less dense than cool) (McArdle, Katch & Katch, 2007). When the air temperature 
is greater than skin temperature, the body will gain heat from the surrounding air 41 
 
and conversely, when skin temperature is greater than air temperature, there will 
be a loss of heat from the body (McArdle, Katch & Katch, 2007). This rate of 
convective exchange is dictated by differences between the skin and air 
temperature along with the rate of air movement over the skin (McArdle, Katch & 
Katch, 2007).  
Conduction. 
Conduction refers to the process of heat moving down its warmer thermal 
gradient to the cooler object upon contact, with the heat energy being transferred 
from molecule to molecule (McArdle, Katch & Katch, 2007). This temperature 
transfer continues until the temperature of the two objects is equalized, and the 
rate of this heat transfer depends on two key factors: the temperature between the 
two objects, and the thermal conductivity of the two objects (McArdle, Katch & 
Katch, 2007).  
Radiation. 
The surface of the human body is constantly emitting heat in the form of 
electromagnetic waves through a process known as radiation, with the absolute 
temperature of the radiating surface determining the rate of emission (McArdle, 
Katch & Katch, 2007). The temperature difference between the surface of the 
body and the average temperature of the various surfaces in the surrounding 
environment determines if net heat is lost or gained, with the rate of heat loss or 
gain being directly dependent on the temperature difference (McArdle, Katch & 
Katch, 2007). 
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Evaporation. 
Evaporation describes the process of transforming water (in the form of 
perspiration) from a liquid to a gas and being dissipated from the surface of the 
skin (McArdle, Katch & Katch, 2007). If perspiration drips from the skin or is 
wiped away, no heat will be lost, as it is the liquid to gas transformation process 
that acts to cool the body (McArdle, Katch & Katch, 2007). This active process 
requires energy and is controlled by the sympathetic nervous system, allowing the 
rate at which it occurs (and subsequent heat loss) to be controlled by the body 
(McArdle, Katch & Katch, 2007). When environmental temperatures reach high 
levels (exceeding approximately 36˚C), heat is lost exclusively by evaporation, 
and as the temperature continues to increase, heat is taken up by the body from 
the environment via radiation, conduction, and convection, causing sweating to 
become profuse in order to maintain the balance between heat uptake and heat 
loss by evaporation (McArdle, Katch & Katch, 2007).   
Responses to Heat During Exercise. 
During exercise, heat production is 15-20 times greater than at rest, and has the 
potential to raise core body temperature 1˚C every five minutes if there are no 
thermoregulatory adjustments (Nadel, Wenger, & Roberts, 1977; cited in Coris, Ramirez, 
& Van Durme, 2004). In order to avoid significant hyperthermia, mechanisms such as 
conduction, convection, radiation, and evaporation are responsible for cooling the body‟s 
core temperature that is raised by the generated heat as well as ambient heat from the 
external environment (Bouchama & Knochel, 2002; Armstrong et al., 1996; Simon, 
1993; cited in Coris et al., 2004). While all cooling mechanisms will contribute to lower 43 
 
core temperature, evaporation as perspiration is responsible for the majority of heat 
dissipation, with research suggesting that in hot, dry conditions, evaporation may be 
responsible for as much as 98% of heat dissipation (Armstrong & Maresh, 1993; cited in 
Coris et al., 2004).  
Dehydration can not only affect a rise in core body temperature, but also a 
considerable decrease in athletic performance, work capacity, or both with as little as 2-
3% dehydration. In addition, factors that limit evaporation such as high humidity or 
dehydration can have profound effects on physiological function, athletic performance, 
and risk for heat illness (Casa, Armstrong, Hillman et al., 2000; Armstrong, Costill, & 
Fink, 1985; cited in Coris et al., 2004). 
 Physiological adaptations to exercising in the heat can be made by the body by a process 
referred to as heat acclimatization; a term that describes the collective physiologic 
adaptive changes that act to improve tolerance to heat exposure such as improved 
cutaneous blood flow, lowered threshold for the start of perspiration, lowered salt 
concentration of perspiration, and less reliance on carbohydrate catabolism during 
exercise (McArdle, Katch & Katch, 2007). Other changes observed as a result of heat 
acclimatization include a decrease in heart rate and core body temperature (indicative of 
lessened physiologic strain) as well as an increase in blood plasma (Casa, 1999). In 
addition, an individual‟s body composition can significantly affect their tolerance to heat 
exposure when exercising. A large overweight individual (with a high level of body fat) 
will expend more energy than a leaner individual when moving their body mass, resulting 
in increased metabolic heat production (Armstrong, 2003). The elevation of body 
temperature is higher, for a given heat load and per kilogram of body mass, in obese 44 
 
individuals compared with those who are not, putting obese individuals at an increased 
risk of becoming hyperthermic during exercise (Armstrong, 2003). In addition, large 
individuals with high levels of muscle mass may also be at an increased risk of 
hyperthermia due to the level of metabolic heat produced by muscles during exercise 
(Armstrong, 2003). With regard to gender differences in heat acclimatization, early 
research suggested that men exhibited a greater tolerance to environmental heat stress 
than women during a standard bout of exercise; however, this research was severely 
flawed as it required women to exercise at a higher percentage of aerobic capacity than 
men (McArdle, Katch & Katch, 2007). When researchers controlled for this factor, the 
differences in thermoregulation were less pronounced when comparing men and women 
of equal fitness (or exercising both at the same percentage of VO2 max) (Drinkwater et 
al., 1976; Horstmen & Christensen, 1982; cited in McArdle, Katch & Katch, 2007). In 
contrast to this, Grogan & Hopkins (2002) suggests that the body temperature at which 
thermoregulatory mechanisms are activated is lower in women than in men, with women 
appearing to store less heat than men for a given workload. Because of this, women seem 
to be more “protected” from the onset of exertional heat stroke than men, and very rarely 
are cases of exertional rhabdomyolosis reported (Grogan & Hopkins, 2002). While the 
exact reason for this difference is unknown, the author suggests several possible 
explanations, including the effect of estrogen or men having a greater ability to generate 
heat due to larger muscle mass (Grogan & Hopkins, 2002).   
ECG Changes Observed During Heat Exposure and Exercise in Hyperthermic Conditions 
Exposure to a hyperthermic environment has been shown in several cases to alter 
cardiovascular function and provide abnormal ECG readings (Rautaharju, Wolf, Piironen, Äikäs, 45 
 
& Karvonen, 1966; Akhtar, Al-Nozha, Al-Harthi, & Nouh, 1993). This has been reported in both 
sedentary exposure to ambient heat (Rautaharju et al., 1966) and in cases where prolonged 
exposure to heat combined with some magnitude of physical stress has lead to heat stroke 
(Akhtar et al., 1993). The condition of heat stroke, defined by three common symptoms: 
hyperthermia (rectal temperature in excess of 41˚C), hot, dry skin combined with an absence of 
perspiration, and severe central nervous system disturbances, occurs when the body is unable to 
cool itself to normal levels (36.5 – 37.5˚C core temperature) when exposed to hot and/or humid 
conditions (Akhtar et al., 1993). The work of Akhtar et al. (1993) examined Hajj pilgrims (mean 
age 59.6 years) from different parts of the world that had been admitted to a medical center 
diagnosed with heat stroke after performing the Hajj pilgrimage in Mecca (or other holy places), 
with ECGs recorded 12 and 24 hours after cooling. Common ECG changes observed included an 
increased Q-T interval, sinus tachycardia, and diffuse ST-T changes that were highly suggestive 
of myocardial ischemia. In addition, other parameters such as atrial fibrillation, intraventricular 
conduction defect, right bundle branch block, and acute myocardial infarction were also present 
(Akhtar et al., 1993). While parameters such as sinus tachycardia and increased Q-T interval had 
normalized in many of the patients 24 hours after cooling, patients suffering from atrial 
fibrillation and paroxysmal supraventricular tachycardia required further treatment (Akhtar et al., 
1993).  
Rautaharju et al. (1966) examined changes in ECG readings and cardiovascular function 
in a participant group that had prolonged exposure to a very high ambient temperature while 
sedentary. Following a period of rest in a room of 25˚C while heart rate and body temperature 
were stabilized, the nude participants were required to move into an environmental chamber and 
remain in a supine position. The period of exposure ranged from 27 to 28 minutes, with the air 46 
 
temperature at the level of the participant varying from 76 to 78˚C, and the mean temperature at 
the site occupied by the participant varying from 83 to 88˚C (Rautaharju et al., 1966). The 
authors noted common changes that would be observed on an ECG reading in a participant 
exposed to thermal stress, including shortening of the S-T segment, flattening of the T wave in 
lead X, and a lack of any obvious changes in the QRS complex (Rautaharju et al., 1966). In the 
present study, results showed a significant decrease in the magnitude of the ventricular gradient 
(VG) during thermal stress, as well as large but inconsistent changes in its orientation; almost no 
change was observed in the magnitudes of the QRS area vectors (Rautaharju et al, 1966). In 
addition, HR increased from a mean of 66 bpm at rest to an average value of 109 bpm after 25 
minutes of exposure to thermal stress, with a range of 96 to 141 bpm (Rautaharju et al., 1966).    
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Chapter 3: Methodology 
Participant Selection and Exclusion Criteria 
Participants used in the study were student-athletes enrolled at Indiana State University, 
participating in one or more of the following NCAA Division I representative sports: track and 
field, cross country, and golf. From these demographics, a total of 11 participants (male n=5; 
female n=6) took part in the study. If potential participants met one or more of the following 
criteria, they were excluded from participating further in the study. Reasons for exclusion were 
as follows: 
1) previously diagnosed or current cardiac abnormalities, 2) family history of cardiac 
abnormalities, 3) idiopathic syncope, 4) diabetes, 5) cancer, 6) medications that affect 
heart rate or blood pressure, 7) pituitary disease, 8) amenorrhea (amenorrheic for three or 
more months), 9) history of heat related illnesses, 10) thyroid disease, 11) sedentary, 12) 
pregnant or planning on becoming pregnant, 13) smokers (current or that have quit within 
the last six months), 14) hypertension, and 14) exercise induced asthma.   
Pre-Test Procedure 
Participants were required to sign and date an informed consent document before taking 
part in the study (APPENDIX A).   In addition, participants were also required to complete a 
health history questionnaire which covered general health history, as well as more specific 
questions on personal and family cardiac health history (APPENDIX A). Participants were 
encouraged to eat a similar meal prior to starting any of the physical testing and ECG data 48 
 
collection to ensure as much consistency as possible. Participant were also instructed to abstain 
from caffeine or alcohol for at least 24 hours prior to reporting to the laboratory for testing and 
were required to follow a hydration protocol to ensure they arrived at the laboratory adequately 
hydrated to perform the tests (APPENDIX A). 
Furthermore, a daily health questionnaire was completed every day of data collection to 
ensure that the participant was feeling well prior to beginning the testing protocol (APPENDIX 
A).   
Testing Procedure 
Participants were required to report to the Exercise Physiology Laboratory on the campus 
of Indiana State University for testing on three separate occasions. The first visit consisted of 
having the participants read and sign the informed consent (during which time participants were 
encouraged to voice any questions or concerns they may have about the testing), answer the 
health-history questionnaire (APPENDIX A), and become familiar with the equipment used for 
data collection during treadmill tests. This familiarization process included a brief introduction to 
the treadmill where participants were exposed to a variety of speeds and gradients in order to 
help determine the initial starting speed for the formal treadmill tests. Following baseline data 
collection (age, height, weight, body fat, blood pressure, resting ECG), participants performed a 
maximal VO2 test on the treadmill to allow for determination of the appropriate intensity for the 
submaximal tests in the subsequent two visits (Maximal Aerobic Test below) 
Anthropometric Data Collection 
Body fat data was collected using skinfold measurements from seven sites for both males 
and females (chest, abdominal, thigh, midaxillary, triceps, subscapular, and suprailiac) using the 
specific site locations outlined by the ACSM (Thompson, Gordon, & Pescatello, 2009). The 49 
 
Jackson and Pollock equation was used to estimate body density. In order to calculate body fat 
percentage, the Siri equation of [(4.95/Db) – 4.5] x 100 was used for Caucasian and African 
American female participants, where Db = body density (g/cm
3). For African American male 
participants, ACSM guidelines that suggest that a more applicable formula of [(4.37/Db) – 3.93] 
x 100 should be used for those aged 18-32 was followed (Thompson et al., 2009). 
Maximal Aerobic Test 
Prior to the beginning of the testing, participants had ECG readings recorded while they 
were standing, seated, supine, and hyperventilating (to simulate a condition of physical stress). 
The maximal test was performed on a treadmill and followed a modified Bruce/Olympic 
protocol (Paavolainen, Häkkinen, Hämäläinen, Nummela, & Rusko, 1999). The initial speed was 
determined by the participant.  Participants were instructed to set the speed at a pace slightly 
higher than they were comfortable running at for an extended period of time (10-15 minutes). To 
ensure the speed was set solely based off comfort and feeling without any influence of the actual 
miles per hour figure, the speed indicator was covered on the treadmill and participants were 
instructed to adjust the speed until they felt it was at the appropriate level. The speed that was 
determined by the participants remained constant throughout the duration of the test. The first 
three minutes of the test were at a gradient of 0% but following this initial stage, the gradient 
increased by 1% every minute until the participant reached exhaustion. During the test, 
participants had respiratory and cardiovascular data recorded such as volume of O2 and CO2 
(VO2, VCO2), respiratory exchange ratio (RER), ventilatory exchange (VE) and heart rate (HR). 
In addition, ratings of perceived exertion (RPE) were  also recorded using the Borg (1998) scale 
(6-20) at the end of each three minute stage, as this aided in determining how close the 
participant was  to reaching exhaustion. Following completion of the test, the gradient was 50 
 
immediately returned back to 0%, treadmill speed reduced, and participants were required to 
remain jogging/walking on the treadmill until their heart rate returned to a normal level (within 
20-30 bpm of recorded resting heart rate). Fluids were readily available at this time for 
participants to re-hydrate.  
While the goal of the test was for participants to terminate the test where they felt at the point 
of maximal exertion, steps were in place in the event that the investigators were required to 
terminate the test before maximal exertion was achieved. In the event that it was necessary, any 
one of the following criteria outlined by the ACSM (Thompson et al., 2009) would have 
facilitated one of the investigators to stop the test immediately:  
  Onset of angina or angina-like symptoms 
  Drop in systolic blood pressure (BP) of >10 mm Hg from baseline BP despite an increase 
in workload 
  Excessive rise in BP: systolic pressure >250 mm Hg or diastolic pressure >115 mm Hg 
  Shortness of breath, wheezing, leg cramps, or claudication 
  Signs of poor perfusion: light-headedness, confusion, ataxia, pallor, cyanosis, nausea, or 
cold and clammy skin 
  Failure of heart rate to increase with increased exercise intensity 
  Noticeable change in heart rhythm 
  Participant requests to stop 
  Physical or verbal manifestations of severe fatigue  
  Failure of the testing equipment 
The test was performed in a thermo-regulated laboratory at a temperature of 24.8 ﾱ 1.6˚C 
(23.3 – 27.8˚C).  51 
 
Submaximal Test at Ambient Temperature 
Baseline data recorded during the maximal treadmill test was used to determine where 
the submaximal threshold was set and maintained by the participants.  The threshold was set at 
70% of the participant‟s maximal oxygen uptake (VO2 max) and participants were asked to 
maintain this workload for anywhere up to 30 minutes. Prior to the beginning of testing, 
participants had resting ECG readings recorded while standing, seated, and supine. As with the 
maximal test, where the test finished was entirely the decision of the participant, but participants 
were encouraged to run for as long as possible within the time limit. Respiratory data was 
collected until the investigators observed the 70% of maximum VO2 threshold, at which time the 
neoprene mask was removed and the participant continued running until voluntary termination or 
the 30 minute time limit was reached. During the test, participants were continuously monitored 
through a 12-lead ECG.  There were momentary pauses (30-40 seconds) in the test at five minute 
intervals to better examine the ECG data and minimize interference caused by the running 
movement which would have increased the difficulty of interpreting the ECG readings. At five 
minute intervals, participants were required to straddle the treadmill belt and remain still while 
the ECG printed a reading. Once a reading was achieved with minimal or no interference, 
participants lowered themselves back onto the belt and continued running. Before stepping back 
onto the treadmill belt, the speed and gradient was lowered to ensure participant safety. Once 
they had gained balance on the belt, the speed and gradient were increased to their previous 
levels. The submaximal testing also followed the same initial protocol as used in the maximal 
test with regard to the starting treadmill speed and gradient of 0%, however, the gradient was 
only increased to a point where the participant was at a workload of 70% of their VO2 max. 
Following completion of the test, participants were required to complete a jogging/walking cool 52 
 
down on the treadmill in the same manner as the maximal test (until heart rate returned to 20-30 
bpm or recorded resting rate). Fluids were available ad libitum to participants while performing 
the test and cool down. The test was performed in a thermo-regulated laboratory at a temperature 
of 24.8 ﾱ 1.6˚C (23.3 – 27.8˚C). 
Submaximal Test in Hyperthermic Environment 
As an additional stressor to the running workload, participants took part in a second 
submaximal test while placed in an environmental chamber, set at a temperature of 38˚C 
(100.4˚F) where they were required to perform a submaximal treadmill test following the same 
protocol as the previous submaximal test and using the same termination point as the ambient 
temperature submaximal test (70% of VO2 max).  
Water and/or an electrolyte replacement beverage (Powerade/Gatorade) was available to 
the participants to consume ad libitum during the test. The hydration protocol was required to be 
followed the night prior to the test, and participants were also instructed to consume regular 
fluids (excluding caffeine and alcohol) during the hours leading up to the test to aid in maintain 
hydration levels. During the test, participants were monitored through a 12-lead ECG. 
Analysis of ECG Testing 
ECG Classifications. 
Analysis of ECGs will be defined based on adapted guidelines proposed by 
Pelliccia et al., 2000):   
Distinctly Abnormal ECG. 
These ECGs would be strongly suggestive of cardiovascular disease. 
Criteria for this diagnosis includes: (1) striking increase in R or S wave 
voltage (≥35 mm) in any lead, (2) Q waves ≥4 mm in depth and present in 53 
 
≥2 leads, (3) repolarization pattern with inverted T wave >2 mm in ≥2 
leads, (4) left bundle branch block, (5) marked left (≤-30°) or right (≥110°) 
QRS axis deviation, and (6) Wolff-Parkinson-White pattern. 
Mildly Abnormal ECG. 
These ECGs would be compatible with the presence of cardiovascular 
disease. Criteria for this diagnosis includes: (1) increased R or S wave 
voltage (30 to 34 mm) in any lead; (2) Q waves 2 to 3 mm in depth and 
present in ≥2 leads; (3) repolarization patterns with either flat, minimally 
inverted, or particularly tall (i.e, ≥15 mm) T waves in ≥2 leads; (4) 
abnormal R wave progression in the anterior precordial leads; (5) right 
bundle branch block (RSR
1 pattern ≥0.12 s in V1 and V2); (6) right atrial 
enlargement (peaked P waves ≥2.5 mm in leads II, III, or V1); (7) left 
atrial enlargement (prolonged positive P wave in lead II and/or deep, 
prolonged negative P wave in V1); and (8) short PR interval (≤0.12 s). 
Normal ECG or ECG with Minor Alterations. 
These ECGs would either be completely normal or showed minor 
alterations that could be attributed to athlete‟s heart syndrome. Criteria for 
this diagnosis includes: (1) increased PR interval duration (>0.20 s), (2) 
mild increase in R or S wave voltage (25 to 29 mm), (3) early 
repolarization (ST elevation ≥2 mm in >2 leads), (4) incomplete right 
bundle branch block (RSR
1 pattern in V1 and V2 of <0.12 s in duration), 
and (5) sinus bradycardia <60 bpm. 
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Statistical Analysis 
The baseline characteristics of the groups were analyzed using One-way analysis of 
variance (ANOVA). A 2 x 4 repeated measures ANOVA was used to test the effects of condition 
(thermoneutral, hyperthermic) by time (baseline, 5 minutes, 10 minutes, 15 minutes) on the 
changes in R and S wave voltage, PR interval duration, and ST elevation/depression. The 
analysis of ECG abnormalities was performed by coding the ECG based on adapted criteria from 
Pelliccia et al. (2000). If an interaction was deemed significant, a Tukey‟s HSD test was used for 
post-hoc comparisons.  Significance was set a priori at p<0.05.  Values are presented as mean ± 
SEM.  All statistical analyses were performed using SPSS Version 18 (SPSS, Inc., Chicago, IL, 
USA).   
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Indiana State University 
HEALTH HISTORY QUESTIONNAIRE 
Study Title: Prevalence of Cardiac Abnormalities in Male and Female College Athletes When Exposed to 
Physiological and Thermal Stressors. 
Participant ID:                                                                                                                                Date: 
Please answer the following questions to the best of your knowledge: 
1.  Are you currently an NCAA athlete involved in one or more of the following 
representative sports:  football, basketball, track and field, softball, cross country, 
soccer, golf, volleyball, and baseball. 
Yes  No 
2.  Are you currently under a doctor‟s care?  Yes  No 
3.  Women only: Are you pregnant or are you planning on becoming pregnant?  Yes  No 
4.  Women only: Are you currently amenorrheac (have not had a period for three or more 
months) for reasons other than birth control? 
Yes  No 
5.  Do you have a pacemaker or automatic implanted cardiac defibrillator (AICD)?  Yes  No 
6.  Do you have, or suspect that you have, any circulatory problems or vascular (problems 
with your veins or arteries) disorders, conditions, disorders, or diseases? 
Yes  No 
7.  Do you have, or suspect that you have, any rheumatoid (joint) or muscular conditions, 
disorders or diseases? 
Yes  No 
8.  Has your doctor ever told you that you may have a heart valve problem?  Yes  No 
9.  Do you experience numbness, tingling, or decreased sensation in extremities, or have 
other neurological problems, conditions, disorders, or diseases? 
Yes  No 
10.  Do you have any problems, conditions, disorders or diseases that affect your ability to 
keep your balance? 
Yes  No 
11.  Are you currently taking any prescription medications? 
If YES, please list all prescription medications.   
 
 
 
Yes  No 
12.  Are you taking any over-the-counter medications or supplements? 
If YES, please list below. 
 
 
 
Yes  No 
13.  Have you suffered from a lower extremity injury in the past 6 months?  Yes  No 
14.  Has your doctor ever told you that you have heart disease?  Yes  No 
15.  Have you ever had a heart attack?  Yes  No 
16.  Have you ever had a stroke?  Yes  No 
17.  Have you ever had chest pain when exercising?  Yes  No 
18.  Has your doctor ever told you that you have a heart murmur?  Yes  No 
19.  Does anyone in your immediate family have any important cardiac conditions? 
(e.g. Marfan syndrome, long-QT syndrome) 
Yes  No 
20.  Has your doctor ever told you that you have high blood pressure?  Yes  No 66 
 
21.  Have you had a heart aneurysm?  Yes  No 
22.  Have you ever had thyroid disease?  Yes  No 
23.  Are you currently a smoker or have quit within the last six months?  Yes  No 
24.  Do you suffer from exercise induced asthma? 
 
Yes  No 
25.  Have you ever fainted for any unknown reasons?  Yes  No 
26.  Have you experienced any heat illnesses such as heat exhaustion or heat stroke?  Yes  No 
27.  Have you been told that you are a diabetic?  Yes  No 
28  Have you been told that you have cancer?  Yes  No 
29.  Are there any other medical problems (past or present) not already mentioned that we 
should know about? If YES, please explain below: 
Yes  No 
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Participant Informed Consent 
Prevalence of Cardiac Abnormalities in Male and Female College Athletes When Exposed 
to Physiological and Thermal Stressors 
You have been asked to take part in a research project that looks at the effect of treadmill 
running in a normal temperature and in a heated room on how your heart functions. Matthew A 
Tucker, a graduate student at Indiana State University, is the primary investigator on this study 
while Drs. Derek Kingsley, and Susan Yeargin are co-investigators.  Your participation in this 
study is entirely voluntary and you are able to stop your involvement at any time.  Please read 
the information below with the investigator and ask questions at anytime about anything you do 
not understand, before deciding whether or not to take part. 
Purpose of the Study. 
The purpose of this study is to look at how treadmill running in different 
environments (normal temperature, 73-75˚F and hot temperature, 100.4˚F) affects your 
heart and how it functions.  This will allow us to look for any unusual activity that might 
be going on with your heart. By doing this, we can hope to gain a better understanding of 
how common non-life threatening heart disorders in a safe environment are in college-
aged athletes; giving us data that may one day help in having more thorough screening 
processes for college athletes before they are allowed to participate in sports.   
Procedures. 
The investigators Matt Tucker and Dr. Derek Kingsley have explained the 
requirements and procedures for the four laboratory visits and the time commitment that 
this will involve. I understand and accept the requirements of participating in these tests. 
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Checklist:                 Initial 
Health history questionnaire   
Order of testing    
Metabolic cart   
Environmental chamber   
ECG machine and electrodes   
Private lockable bathroom   
Rectal thermometer emergency protocol   
Anthropometric data collection equipment   
Treadmill – participant can safely maneuver themselves      
off and back onto the treadmill (if „No‟, repeat until        Yes  No 
satisfactory).   
      Date 
Potential Risks and Discomforts. 
There are possible risks involved with this study when performing maximal or 
near maximal tests. The American College of Sports Medicine (ACSM) lists criteria for 
stopping a test early as meeting one or more of the following conditions: onset of angina 
or angina-like symptoms, drop in systolic blood pressure (BP) of >10 mm Hg from 
baseline BP despite an increase in workload, excessive rise in BP, shortness of breath, 
wheezing, leg cramps, or calf cramping, signs of poor perfusion: light-headedness, 
confusion, ataxia (inability to walk), pallor (white, ashen skin), cyanosis (blue fingernail 
beds or lips), nausea, or cold and clammy skin, failure of heart rate to increase with 
increased exercise intensity, noticeable change in heart rhythm, and failure of the testing 69 
 
equipment. In addition, there is also the risk of a cardiac abnormality occurring such as 
an arrhythmia (an abnormal heart rhythm); however, the chances of a serious abnormality 
occurring will be minimized through pre-screening questionnaires before you take part in 
any testing and during testing, investigators will be monitoring your ECG which will 
show us if there is any abnormality occurring which would require the test to stop. 
  Because the tests will be completed on a treadmill, there is the risk of possibly 
falling off while the treadmill is in motion. At all times during testing, the treadmill will be 
surrounded by padding, and one of the investigators will act as a spotter so that in the event 
that you do fall off, you will be well protected and the risk for injury is minimized. There 
will be an ice bath ready when you take part in the submaximal test in the heat so that we 
can cool your core body temperature quickly if it gets too high during the test.  It‟s not 
likely that this will be needed, but it will be there as a precaution. Secondly, any testing 
that involves maximal effort or combines exercise with a heated environment has some 
level of risk; however, there are steps in place to make sure you are safe while taking part 
in this study, such as keeping a close focus on your data and physical condition so that we 
are ready to step in and stop the test if need be. In addition, we will ensure that you meet 
the ACSM‟s criteria to be considered low risk before any testing takes place.  
Potential Benefits to Participants and/or Society. 
 There are no direct benefits to participants or society, only inferred. 
Compensation to Participate. 
  There will be no compensation for participating in this study.  
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Confidentiality. 
Any information that is obtained during this study that can identify you will 
remain confidential and will be revealed only with your permission, as required by law.  
Your health history questionnaire and the informed consent will be kept in separate 
locked cabinets in secure rooms after the investigators, Matt Tucker and Dr. Derek 
Kingsley, review it for safety reasons. To make sure your identity is kept confidential, an 
ID number will be given to the data that we collect from your testing.  The master sheet 
with your ID number and name will be kept in a locked cabinet during the study that only 
the investigators will have access to. It will be stored in a separate location from the 
questionnaires and collected data so that your confidentiality can be maintained. All 
collected data from testing and informed consent documents will be stored for three years 
after completion and will be destroyed (shredded) at the end of this time. The master key 
that identifies you from the ID number given to you will be destroyed immediately 
following completion of testing. Health history questionnaires and current health 
questionnaires will be stored in a locked cabinet in Dr. Kingsley‟s office, separate from 
the collected data and informed consent documents, for seven years and will be destroyed 
(shredded) at the end of this time. The results of this study will be published in a 
summary format and there will be no way for anyone to identify that you participated in 
this study. 
Participation and Withdrawal. 
You can choose whether or not to be in this study if you are aged between 18 and 
30 years old.  If you volunteer to be in this study, you may withdraw at any time without 
penalty or consequences, or loss of benefits to which you are otherwise entitled. In the 71 
 
unlikely event that physical injury results from your participation in this study, you will 
be provided with on-site emergency medical treatment at no cost to you.   
Costs of Participation. 
In the event that medical attention is required past that which can be provided by 
the investigators in the Exercise Physiology laboratory, the cost of additional medical 
treatment (e.g., student health center, hospital emergency room) will be your 
responsibility and financial compensation is not available from Indiana State University 
or the investigators. 
Identification of Investigators. 
If you have any questions or concerns about participating in this research project, please 
contact Matt Tucker or Dr. Derek Kingsley.  
Primary Investigator: Matt Tucker        
                                       Arena C-54 
                                       Graduate Assistant  
                                       Indiana State University 
                                       (812) 243-5814 
                                       Email: mtucker15@indstate.edu           
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Faculty Sponsor/Co-Investigators:   
Dr. Derek Kingsley,   Dr. Susan Yeargin, ATC 
Arena C-34  Student Services Bldng, Rm 246 
Indiana State University  Indiana State University 
Terre Haute, IN 47809  Terre Haute, IN 47809 
Office: (812) 237-2594  Office: (812) 237-3962 
Email: Derek.kingsley@indstate.edu  Email: Susan.yeargin@indstate.edu 
Rights of Research Subjects. 
If you have any questions about your rights as a research subject, you may contact 
the Indiana State University Institutional Review Board (IRB) by mail at 114 Erickson 
Hall, Terre Haute, IN 47809, by phone at (812) 237-8217, or e-mail the IRB at 
irb@indstate.edu. You will be given the opportunity to discuss any questions about your 
rights as a research subject with a member of the IRB. The IRB is an independent 
committee composed of members of the University community, as well as lay members 
of the community not connected with ISU. The IRB has reviewed and approved this 
study. I understand the procedures described above. My questions have been answered to 
my satisfaction, and I agree to participate in this study.  
   
Printed Name of Subject 
           
Signature of Subject              Date 
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APPENDIX B: Analyses 
PR Interval ANOVA Table 
Mauchly's Test of Sphericity
b 
 
Within 
Subjects 
Effect 
Mauchly's W 
Approx. Chi-
Square  df  Sig. 
Epsilon
a 
Greenhouse-
Geisser  Huynh-Feldt  Lower-bound 
cond  1.000  .000  0  .  1.000  1.000  1.000 
time  .402  6.123  5  .299  .655  .867  .333 
cond * time  .287  8.397  5  .139  .654  .865  .333 
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed dependent variables is 
proportional to an identity matrix. 
a. May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected tests are displayed 
in the Tests of Within-Subjects Effects table. 
b. Design: Intercept + Group  
 Within Subjects Design: cond + time + cond * time 
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Tests of Within-Subjects Effects. 
 
Source  Type III 
Sum of 
Squares  df 
Mean 
Square  F  Sig. 
Partial Eta 
Squared 
Noncent. 
Parameter 
Observed 
Power
a 
cond  Sphericity 
Assumed 
117.556  1  117.556  .557  .477  .065  .557  .101 
                 
Huynh-Feldt  117.556  1.000  117.556  .557  .477  .065  .557  .101 
                 
time  Sphericity 
Assumed 
11480.500  3  3826.833  31.343  .000  .797  94.030  1.000 
                 
Huynh-Feldt  11480.500  2.601  4413.160  31.343  .000  .797  81.537  1.000 
                 
cond * time  Sphericity 
Assumed 
208.111  3  69.370  .870  .470  .098  2.611  .211 
                 
Huynh-Feldt  208.111  2.595  80.210  .870  .459  .098  2.258  .196 
                 
a. Computed using alpha = .05 
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R Wave ANOVA Table 
Mauchly's Test of Sphericity
b 
 
Within Subjects 
Effect  Mauchly's W 
Approx. Chi-
Square  df  Sig. 
Epsilon
a 
Greenhouse-Geisser  Huynh-Feldt  Lower-bound 
cond  1.000  .000  0  .  1.000  1.000  1.000 
time  .438  5.543  5  .358  .693  .940  .333 
cond * time  .421  5.814  5  .329  .698  .951  .333 
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed dependent variables is 
proportional to an identity matrix. 
a. May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected tests are displayed 
in the Tests of Within-Subjects Effects table. 
b. Design: Intercept + Group  
 Within Subjects Design: cond + time + cond * time 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 77 
 
 
Tests of Within-Subjects Effects.  
Source  Type III 
Sum of 
Squares  df 
Mean 
Square  F  Sig. 
Partial Eta 
Squared 
Noncent. 
Parameter 
Observed 
Power
a 
cond  Sphericity 
Assumed 
9.389  1  9.389  4.250  .073  .347  4.250  .442 
                 
Huynh-Feldt  9.389  1.000  9.389  4.250  .073  .347  4.250  .442 
                 
time  Sphericity 
Assumed 
130.681  3  43.560  10.613  .000  .570  31.839  .996 
                 
Huynh-Feldt  130.681  2.821  46.317  10.613  .000  .570  29.943  .994 
                 
cond * 
time 
Sphericity 
Assumed 
5.750  3  1.917  .861  .475  .097  2.582  .209 
                 
Huynh-Feldt  5.750  2.852  2.016  .861  .471  .097  2.455  .203 
                 
a. Computed using alpha = .05 
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S Wave ANOVA Table 
Mauchly's Test of Sphericity
b 
 
Within Subjects 
Effect 
Mauchly's W 
Approx. Chi-
Square  df  Sig. 
Epsilon
a 
Greenhouse-Geisser  Huynh-Feldt  Lower-bound 
cond  1.000  .000  0  .  1.000  1.000  1.000 
time  .340  7.243  5  .207  .650  .856  .333 
cond * time  .141  13.158  5  .023  .562  .696  .333 
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed dependent variables is 
proportional to an identity matrix. 
a. May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected tests are displayed 
in the Tests of Within-Subjects Effects table. 
b. Design: Intercept + Group  
 Within Subjects Design: cond + time + cond * time 
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Tests of Within-Subjects Effects. 
 
Source  Type III 
Sum of 
Squares  df 
Mean 
Square  F  Sig. 
Partial Eta 
Squared 
Noncent. 
Parameter 
Observed 
Power
a 
cond  Sphericity 
Assumed 
.056  1  .056  .049  .830  .006  .049  .054 
                 
Huynh-Feldt  .056  1.000  .056  .049  .830  .006  .049  .054 
                 
time  Sphericity 
Assumed 
18.056  3  6.019  9.706  .000  .548  29.118  .993 
                 
Huynh-Feldt  18.056  2.568  7.032  9.706  .001  .548  24.923  .984 
                 
cond * time  Sphericity 
Assumed 
.278  3  .093  .607  .617  .071  1.822  .157 
                 
Huynh-Feldt  .278  2.089  .133  .607  .563  .071  1.269  .136 
                 
a. Computed using alpha = .05 
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ST Segment ANOVA Table 
Mauchly's Test of Sphericity
b 
 
Within Subjects 
Effect 
Mauchly's W 
Approx. Chi-
Square  df  Sig. 
Epsilon
a 
Greenhouse-Geisser  Huynh-Feldt  Lower-bound 
cond  1.000  .000  0  .  1.000  1.000  1.000 
time  .119  14.313  5  .015  .491  .574  .333 
cond * time  .198  10.898  5  .056  .543  .662  .333 
Tests the null hypothesis that the error covariance matrix of the orthonormalized transformed dependent variables is 
proportional to an identity matrix. 
a. May be used to adjust the degrees of freedom for the averaged tests of significance. Corrected tests are displayed 
in the Tests of Within-Subjects Effects table. 
b. Design: Intercept + Group  
 Within Subjects Design: cond + time + cond * time 
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Tests of Within-Subjects Effects. 
 
Source  Type III 
Sum of 
Squares  df 
Mean 
Square  F  Sig. 
Partial Eta 
Squared 
Noncent. 
Parameter 
Observed 
Power
a 
cond  Sphericity 
Assumed 
.347  1  .347  3.883  .084  .327  3.883  .411 
                 
Huynh-Feldt  .347  1.000  .347  3.883  .084  .327  3.883  .411 
                 
time  Sphericity 
Assumed 
1.681  3  .560  2.620  .074  .247  7.859  .568 
                 
Huynh-Feldt  1.681  1.723  .975  2.620  .114  .247  4.514  .408 
                 
cond * time  Sphericity 
Assumed 
.403  3  .134  1.157  .347  .126  3.471  .271 
                 
Huynh-Feldt  .403  1.987  .203  1.157  .339  .126  2.299  .217 
                 
a. Computed using alpha = .05 
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APPENDIX C: Sample Electrocardiograms 
 
Figure 6. Right bundle branch block. 
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Figure 7. Left ventricular hypertrophy and left bundle branch block. 
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APPENDIX D: Recommendations 
Methodology Improvements 
In order to improve upon the present study, several factors could be altered to provide 
more robust and conclusive results. Firstly, a larger study population would increase the 
statistical power, therefore increasing the robustness of the data. More specifically, participants 
from a wider range of sports could be used, including athletes participating in more 
anaerobic/power sports (i.e. volleyball, basketball, softball, baseball, football, etc.) to test for 
differences that exist in terms of prevalence of cardiac abnormalities among sports. In addition, 
athletes from different ethnic backgrounds could be tested, as previous research has 
demonstrated a considerably higher incidence rate of cardiac abnormalities in African American 
athletes; particularly males.  
Clinical Implications 
While the present study demonstrated a high prevalence of an uncommon ECG 
abnormality in athletes (most notably incomplete left bundle branch block), given the relatively 
low study population, it should be noted that our results are limited in their ability to advance the 
current support for improved pre-screening protocols. The ultimate goal in this line of research is 
to lower the incidence rate of SCD in athletes; however, one should not expect current collegiate 
pre-screening protocols to move from considerably inadequate to adequate in one swift motion, 
rather, that the steps currently in place are improved upon, beginning with the most simplistic 
factor of the pre-screening process: the health history questionnaire. While many athletes will 85 
 
show almost nothing of concern on their pre-screening questionnaire, if something abnormal 
were to show, further investigation by way of a resting ECG may be warranted. Therefore, it is 
the hopes of the authors that this research will help contribute to the eventual inclusion of a 
resting ECG in pre-screening protocols for collegiate athletes, ultimately leading to a decrease in 
incidences of SCD in this population. The ongoing success of the Italian pre-screening model is 
something that should be both commended and embraced as a vision of the future for US 
collegiate athletic programs. 